RxDoctor Payments Data

Albert Tsai, MD

Orthopedic Surgery · Long Beach, CANPI 1700865482

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,235 of the $1,509 with a category attached, or 81.8%. Elevate Surgical Co accounts for 79.5% of it on its own, with 5 other manufacturers making up the rest. 2022 is the largest year on record at $1,267, more than ten times the $60 reported in 2019.

$1,509in general payments, 2019–2025

Across 10 payments — averaging $150.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elevate Surgical Co$1K
  • Stryker$177
  • Johnson & Johnson$61
  • Trevena, Inc.$35
  • Merck$23
  • Pfizer$14

What the payments were for

  • Food & beverage$27418%
  • Education$1,23582%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elevate Surgical Co1$1,200
Stryker2$177
Johnson & Johnson3$61
Trevena, Inc.2$35
Merck1$23
Pfizer1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,509 in reported general payments places this provider in the 60th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$287,098
Medicare patients
508
Services billed
2,480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl33$1,841
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen114$1,486
Cephalexin69$223
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$184
Meloxicam45$163

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →